| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $111.3M | +30.8% |
| SG&A Expense | $32.0M | +17.3% |
| Operating Income | -$143.3M | -27.5% |
| Pre-tax Income | -$135.0M | -24.4% |
| Income Tax | $338K | — |
| Net Income | -$135.4M | -24.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.1M | +133.3% |
| Current Assets | $236.2M | -14.4% |
| Total Assets | $303.8M | -11.3% |
| Current Liabilities | $46.6M | +82.2% |
| Total Liabilities | $124.5M | +75.4% |
| Stockholders' Equity | $179.3M | -34.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.8M | +52.6% |
| Capital Expenditures | $19.0M | +47.5% |
| Investing Cash Flow | $88.8M | +140.5% |
| Financing Cash Flow | $27.5M | +34.3% |
| Free Cash Flow | -$62.8M | +40.4% |